• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: Strengths and Challenges of Allo-SCT in the Modern Era.

作者信息

Malagola Michele, Greco Raffaella, Peccatori Jacopo, Isidori Alessandro, Romee Rizwan, Mohty Mohamad, Ciceri Fabio, Russo Domenico

机构信息

Unit of Blood Diseases and Stem Cell Transplantation, ASST-Spedali Civili di Brescia, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.

出版信息

Front Oncol. 2022 Feb 24;12:850403. doi: 10.3389/fonc.2022.850403. eCollection 2022.

DOI:10.3389/fonc.2022.850403
PMID:35280781
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8907534/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236f/8907534/e88ca561d375/fonc-12-850403-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236f/8907534/e88ca561d375/fonc-12-850403-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/236f/8907534/e88ca561d375/fonc-12-850403-g001.jpg

相似文献

1
Editorial: Strengths and Challenges of Allo-SCT in the Modern Era.
Front Oncol. 2022 Feb 24;12:850403. doi: 10.3389/fonc.2022.850403. eCollection 2022.
2
Cytomegalovirus-specific CD8+ T-cells are associated with a reduced incidence of early relapse after allogeneic stem cell transplantation.巨细胞病毒特异性 CD8+ T 细胞与异基因干细胞移植后早期复发率降低有关。
PLoS One. 2019 Mar 19;14(3):e0213739. doi: 10.1371/journal.pone.0213739. eCollection 2019.
3
Possible Impact of Cytomegalovirus-Specific CD8 T Cells on Immune Reconstitution and Conversion to Complete Donor Chimerism after Allogeneic Stem Cell Transplantation.巨细胞病毒特异性CD8 T细胞对异基因干细胞移植后免疫重建及向完全供体嵌合体转化的潜在影响
Biol Blood Marrow Transplant. 2017 Jul;23(7):1046-1053. doi: 10.1016/j.bbmt.2017.03.027. Epub 2017 Mar 23.
4
Impact of Cytomegalovirus Reactivation and Natural Killer Reconstitution on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Analysis.巨细胞病毒再激活和自然杀伤细胞重建对异基因造血干细胞移植后结局的影响：一项单中心分析
Biol Blood Marrow Transplant. 2020 Jan;26(1):171-177. doi: 10.1016/j.bbmt.2019.09.028. Epub 2019 Sep 26.
5
Deleterious Effect of Steroids on Cytomegalovirus Infection Rate after Allogeneic Stem Cell Transplantation Depends on Pretransplant Cytomegalovirus Serostatus of Donors and Recipients.类固醇对异基因干细胞移植后巨细胞病毒感染率的有害影响取决于供体和受者移植前巨细胞病毒血清学状态。
Biol Blood Marrow Transplant. 2018 Oct;24(10):2088-2093. doi: 10.1016/j.bbmt.2018.05.001. Epub 2018 May 9.
6
γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia.异基因造血干细胞移植后由 CMV 再激活诱导的 γδT 细胞交叉识别 CMV 和白血病。
Leukemia. 2013 Jun;27(6):1328-38. doi: 10.1038/leu.2012.374. Epub 2013 Jan 1.
7
Reconstitution of HLA-A*2402-restricted cytomegalovirus-specific T-cells following stem cell transplantation.干细胞移植后HLA-A*2402限制性巨细胞病毒特异性T细胞的重建
Int J Hematol. 2004 Dec;80(5):441-8. doi: 10.1532/ijh97.04109.
8
Risk factors and associations with clinical outcomes of cytomegalovirus reactivation after haploidentical versus matched-sibling unmanipulated PBSCT in patients with hematologic malignancies.同种异体与同胞相合非清髓 PBSCT 后血液恶性肿瘤患者巨细胞病毒再激活的危险因素及与临床结局的相关性。
Ann Hematol. 2020 Aug;99(8):1883-1893. doi: 10.1007/s00277-020-04156-6. Epub 2020 Jun 22.
9
Rapid reconstitution of CD4 T cells and NK cells protects against CMV-reactivation after allogeneic stem cell transplantation.CD4 T细胞和NK细胞的快速重建可预防异基因干细胞移植后的巨细胞病毒再激活。
J Transl Med. 2016 Aug 2;14(1):230. doi: 10.1186/s12967-016-0988-4.
10
Immune reconstitution and cytomegalovirus infection after allogeneic stem cell transplantation: the important impact of in vivo T cell depletion.异基因干细胞移植后免疫重建和巨细胞病毒感染：体内 T 细胞耗竭的重要影响。
Int J Hematol. 2010 Jun;91(5):877-85. doi: 10.1007/s12185-010-0597-6. Epub 2010 May 21.

引用本文的文献

1
CAR-T Cell Therapies in B-Cell Acute Lymphoblastic Leukemia: Emerging Data and Open Issues.B细胞急性淋巴细胞白血病中的CAR-T细胞疗法：新出现的数据和未解决的问题
Cancers (Basel). 2025 Sep 16;17(18):3027. doi: 10.3390/cancers17183027.
2
Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia.骨髓CD34+分子嵌合作为急性髓系白血病患者异基因干细胞移植后复发的早期预测指标。
Front Oncol. 2023 Mar 6;13:1133418. doi: 10.3389/fonc.2023.1133418. eCollection 2023.

本文引用的文献

1
Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA).成人和儿童接受嵌合抗原受体 T 细胞（CAR T）疗法的管理：欧洲血液和骨髓移植学会（EBMT）、国际干细胞治疗认证委员会和 EBMT（JACIE）联合认证委员会以及欧洲血液学协会（EHA）的 2021 年最佳实践建议。
Ann Oncol. 2022 Mar;33(3):259-275. doi: 10.1016/j.annonc.2021.12.003. Epub 2021 Dec 16.
2
GITMO Registry Study on Allogeneic Transplantation in Patients Aged ≥60 Years from 2000 to 2017: Improvements and Criticisms.2000年至2017年GITMO关于≥60岁患者同种异体移植的登记研究：进展与批评
Transplant Cell Ther. 2022 Feb;28(2):96.e1-96.e11. doi: 10.1016/j.jtct.2021.11.006. Epub 2021 Nov 21.
3
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party.2021 年急性髓系白血病微小残留病更新：来自欧洲白血病网微小残留病工作组的共识文件。
Blood. 2021 Dec 30;138(26):2753-2767. doi: 10.1182/blood.2021013626.
4
The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update.中华血液学分会关于异基因造血干细胞移植适应证、预处理方案及供者选择的专家共识（2021 年版）
J Hematol Oncol. 2021 Sep 15;14(1):145. doi: 10.1186/s13045-021-01159-2.
5
Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.单倍体与同胞相合供者在成人急性淋巴细胞白血病造血干细胞移植中的结局：欧洲血液和骨髓移植学会急性白血病工作组的一项研究。
J Hematol Oncol. 2021 Apr 1;14(1):53. doi: 10.1186/s13045-021-01065-7.
6
Let's reconstitute microbiota diversity.让我们重建微生物群的多样性。
Blood. 2021 Mar 18;137(11):1442-1444. doi: 10.1182/blood.2020009963.
7
Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years.EBMT 造血细胞移植和细胞治疗调查：30 多年来活动和趋势的监测。
Bone Marrow Transplant. 2021 Jul;56(7):1651-1664. doi: 10.1038/s41409-021-01227-8. Epub 2021 Feb 23.
8
Dynamic immune profiling identifies the stronger graft-versus-leukemia (GVL) effects with haploidentical allografts compared to HLA-matched stem cell transplantation.动态免疫分析显示，与 HLA 匹配的干细胞移植相比，半相合同种异体移植具有更强的移植物抗白血病（GVL）效应。
Cell Mol Immunol. 2021 May;18(5):1172-1185. doi: 10.1038/s41423-020-00597-1. Epub 2021 Jan 6.
9
Advances in CMV Management: A Single Center Real-Life Experience.巨细胞病毒管理的进展：单中心真实世界经验
Front Cell Dev Biol. 2020 Oct 27;8:534268. doi: 10.3389/fcell.2020.534268. eCollection 2020.
10
Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades.异基因造血细胞移植联合非清髓性预处理治疗血液系统恶性肿瘤：二十多年来的改善结果。
Haematologica. 2021 Jun 1;106(6):1599-1607. doi: 10.3324/haematol.2020.248187.